QQQ
+ 4.37
590.95
+ 0.73%
BTC/USD
-66.90
115685.50
-0.0578%
DIA
+ 0.31
462.32
+ 0.07%
SPY
+ 1.21
661.05
+ 0.18%
TLT
-0.16
89.35
-0.18%
GLD
+ 3.61
332.01
+ 1.08%

Coronavirus [COVID-19] – A Global Crisis

Cocrystal Pharma Receives Study May Proceed Letter From FDA To Conduct Phase 1b Challenge Study Evaluating CDI-988 For Prevention And Treatment Of Norovirus Infections; Phase 1b Challenge Study Is Planned To Begin Before Year-End 2025

Cocrystal Pharma Receives Study May Proceed Letter From FDA To Conduct Phase 1b Challenge Study Evaluating CDI-988 For Prevention And Treatment Of Norovirus Infections; Phase 1b Challenge Study Is Planned To Begin Before Year-End 2025

Sep. 8th, 2025 7:01am

There are currently no approved vaccines or treatments for norovirus infectionCocrystal's CDI-988 is the first antiviral for the potential prevention and treatment of viral gastroenteritis caused by norovirus
Enanta Sues Pfizer in European Court Over Patent Linked to COVID Drug Paxlovid

Enanta Sues Pfizer in European Court Over Patent Linked to COVID Drug Paxlovid

Aug. 20th, 2025 6:08am

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections and immunological diseases, announced today that it has filed suit
Demystifying Invivyd: Insights From 5 Analyst Reviews

Demystifying Invivyd: Insights From 5 Analyst Reviews

Aug. 19th, 2025 7:03am

Fact Check: Viral Stimulus Check Claims for Summer Are False, IRS Will Not Send New Checks This Summer

Fact Check: Viral Stimulus Check Claims for Summer Are False, IRS Will Not Send New Checks This Summer

RFK Jr. Halts $500 Million In mRNA Vaccine Projects Backed By Pfizer, Moderna: 'We're Prioritizing Safer, Broader Strategies'

RFK Jr. Halts $500 Million In mRNA Vaccine Projects Backed By Pfizer, Moderna: ‘We’re Prioritizing Safer, Broader Strategies’

Cocrystal Pharma Presents Phase 1 Results for Pan-Viral Inhibitor CDI-988 At DOD Medical Conference Including That All Cdi-988 Doses, Ranging From 100 Mg To 1200 Mg In Phase 1 Study Were Well Tolerated& Company Expects To Initiate Phase 1b Study With Cdi-988 In Norovirus-infected Healthy Subjects Later This Year

Aethlon Medical Has Been Granted European Patent Number EP4136453 Titled “LECTIN FOR USE IN METHODS FOR TREATING A SEQUELA OF CORONAVIRUS INFECTION”

Coronavirus Data Studies

Track The Spread of the Coronavirus

March 30th

Italy Reports Lowest Number Of New Coronavirus Cases In Nearly 2 Weeks

March 26th

New Yorkers Hit hard as American Death Toll Passes 1,000

March 25th

Global confirmed cases surge past 500,000

March 5th

The Coronavirus surpasses 100,000 cases globally

February 28th

Global cases hit 86,000 as first American dies

February 21st

2 confirmed cases found in Iran

February 21st

South Korean church linked to outbreak, infecting more than 200

February 14th

First coronavirus death in Europe reported in France

February 13th

More than 14,000 new cases in Hubei Province

February 9th

3,600 passengers quarantined on Diamond Princess

February 2nd

First death reported outside of China

January 20th

The United States, among the first other countries to confirm cases.

January 11th

First death reported in China

December 31st

Chinese authorities treated dozens of cases of pneumonia of unknown cause.

More on Making Money During COVID-19